Blue Jet Healthcare Files BRSR for FY 2025-26

Blue Jet Healthcare Ltd. has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, in compliance with SEBI regulations. The report, available on the company's website, details its corporate identity, operations, products, and employee data. The company's primary business activity is the manufacturing of chemicals, pharmaceuticals, and medicinal products, accounting for 100% of its turnover. Key products include Contrast Media (53%), High Intensity Sweeteners (14%), and Pharmaceutical Intermediaries/APIs (33%). The company operates 8 national locations and serves over 50 countries internationally, with exports contributing approximately 90% of its total turnover. The report is prepared on a standalone basis and has undergone reasonable assurance assessment by TUV India Pvt Ltd.